We have provided evidence that NPC galvanotaxis is moderated by EGF signaling; both the removal of EGF from the culture medium as well as the blockade of EGFR via erlotinib significantly attenuate NPC galvanotaxis. Here, EGFR is linked to nasopharyngeal carcinoma.